Funding for this research was provided by:
Australian Research Council (Future Fellowship: FT130101122)
National Institute of Allergy and Infectious Diseases
National Institutes of Health (AI095192)
Australian Government (Research Training Program Scholarship)
National Health and Medical Research Council of Australia (Australian Centre for Research Excellence in Malaria Elimination: 1134989, Project grant: 1092789, Research Fellowship: 1077636)
PATH's Malaria Vaccine Initiative
Received: 16 November 2018
Accepted: 31 January 2019
First Online: 25 February 2019
Ethics approval and consent to participate
: Parents/guardians of participants provided written informed consent, and ethics approval was obtained by the following: Mozambican National Health and Bioethics Committee; Hospital Clınic of Barcelona Ethics Committee; PATH Research Ethics Committee; Alfred Human Research and Ethics Committee (ethics approval number 174/18).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.